|
|
China Aoxing’s Revenues Climb; Net Income Still Negative
publication date: May 18, 2009
China Aoxing Pharmaceutical Company (中国奥星药业) reported its 2008 third quarter (ended March 31, 2009) results, saying revenues rose 85% to $1.6 million, largely because the company acquired Shijiazhuang Lerentang Pharmaceutical Company Ltd. (LRT) in 2008. LRT is a TCM drug company that, like China Aoxing, focuses on pain medications. China Aoxing said its operating loss in Q3 was $700,000 in Q3, about half the year-earlier period. More details... Stock Symbol: (OTCBB: CAXG)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|